$1.16
+0.03 (+2.65%)
Open$1.17
Previous Close$1.13
Day High$1.18
Day Low$1.14
52W High$2.98
52W Low$0.99
Volume—
Avg Volume117.4K
Market Cap38.08M
P/E Ratio6.50
EPS$0.11
SectorPharmaceuticals
Analyst Ratings
Strong Buy
11 analysts
Price Target
+1,340.5% upside
Current
$1.16
$1.16
Target
$16.71
$16.71
$12.81
$16.71 avg
$20.08
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 172.11M | 163.57M | 22.38M |
| Net Income | 24.22M | 20.71M | 3.27M |
| Profit Margin | 14.1% | 13.4% | 14.6% |
| EBITDA | 33.62M | 30.36M | 5.70M |
| Free Cash Flow | — | — | 2.62M |
| Rev Growth | +5.2% | +5.2% | -5.1% |
| Debt/Equity | 9.02 | 9.02 | 0.18 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |